News
ReNeuron's latest press releases
Notice to Warrant Holders. 15/11/06
Guildford, UK, 15 November 2006: ReNeuron Group plc (LSE: RENE) gives notice reminding Warrant holders that, in accordance with the terms of the …
Read articleReNeuron to present ReN001 Stroke data. 09/10/06
ReNeuron to Present at American Neurological Association Conference Results to Form Part of Data Package to the US FDA In Support of Application to …
Results of 2006 Annual General Meeting. 21/09/06
Guildford, UK, 21 September 2006: ReNeuron Group plc (LSE: RENE) today announces that all resolutions put to its Shareholders at its 2006 Annual …
Warrant Holder Meeting. 21/09/06
Guildford, UK, 21 September 2006: ReNeuron Group plc (LSE: RENE) today announces that all resolutions put to Warrant holders at a meeting of Warrant …
ReNeuron 2006 Annual General Meeting. 23/08/06
Guildford, UK, 23 August 2006: ReNeuron Group plc (LSE: RENE) today announces that it has sent notice to its Shareholders and Warrant holders …
ReNeuron appoints Principal Investigator for Phase l clinical study with its ReN001 stem cell therapy for stroke. 23/08/06
ReNeuron Group plc (LSE: RENE) today announces that it has appointed Professor Douglas Kondziolka MD, MSc, FRCS, FACS as Principal Investigator for …
ReNeuron to present new safety data regarding its stem cell expansion technology and its ReN001 stem cell line for stroke. 29/06/06
Guildford, UK, 29 June 2006: ReNeuron Group plc (LSE: RENE) today announces that it will be presenting significant new data concerning both its c-…
ReNeuron Group plc Preliminary Results for the year ended 31 March 2006. 28/06/06
Operational Highlights Significant progress with late pre-clinical development of lead ReN001 stroke therapy, including repeat efficacy and dose …
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page